ADVERSE OUTCOME;
BIRTH;
DISEASE CONTROL;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
DRUG EXPOSURE;
DRUG SAFETY;
DRUG WITHDRAWAL;
EDITORIAL;
ENTERITIS;
HUMAN;
MEDICAL DECISION MAKING;
PLACENTAL TRANSFER;
POLYDACTYLY;
PRACTICE GUIDELINE;
PREGNANT WOMAN;
REMISSION;
UMBILICAL CORD BLOOD;
UNSPECIFIED SIDE EFFECT;
Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn
Vasiliauskas E.A., Church J.A., Silverman N., et al. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol 2006, 4:1255-1258.
Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy
Kane S.V., Acquah L.A. Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am J Gastroenterol 2009, 104:228-233.
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease
Mahadevan U., Wolf D.C., Dubinsky M., et al. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2013, 11:286-292.
Disease activity in pregnant women with Crohn's disease and birth outcomes: a regional Danish cohort study
Norgard B., Hundborg H.H., Jacobsen B.A., et al. Disease activity in pregnant women with Crohn's disease and birth outcomes: a regional Danish cohort study. Am J Gastroenterol 2007, 102:1947-1954.
Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure
Zelinkova Z., van der Ent C., Bruin K.F., et al. Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure. Clin Gastroenterol Hepatol 2013, 11:318-321.
The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics
Mahadevan U., Cucchiara S., Hyams J.S., et al. The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics. Am J Gastroenterol 2011, 106:214-223.
PIANO: a 1000 patient prospective registry of pregnancy outcomes in women with IBD exposed to immunomodulators and biologic therapy
Mahadevan U., Martin C., Sandler R.S., et al. PIANO: a 1000 patient prospective registry of pregnancy outcomes in women with IBD exposed to immunomodulators and biologic therapy. Gastroenterology 2012, 142:S149.
